141 related articles for article (PubMed ID: 31069822)
41. Prenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood.
Geifman-Holtzman O; Ober Berman J
Expert Rev Mol Diagn; 2008 Nov; 8(6):727-51. PubMed ID: 18999924
[TBL] [Abstract][Full Text] [Related]
42. Role of magnetic resonance imaging in fetuses with mild or moderate ventriculomegaly in the era of fetal neurosonography: systematic review and meta-analysis.
Di Mascio D; Sileo FG; Khalil A; Rizzo G; Persico N; Brunelli R; Giancotti A; Panici PB; Acharya G; D'Antonio F
Ultrasound Obstet Gynecol; 2019 Aug; 54(2):164-171. PubMed ID: 30549340
[TBL] [Abstract][Full Text] [Related]
43. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
Cardo L; García BP; Alvarez FV
Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
[TBL] [Abstract][Full Text] [Related]
44. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
45. Noninvasive first-trimester screening for fetal aneuploidy.
Sherer DM; Bombard AT; Kellner LH; Divon MY
Obstet Gynecol Surv; 1997 Feb; 52(2):123-9. PubMed ID: 9027911
[TBL] [Abstract][Full Text] [Related]
46. [Clinical features of abnormal chromosome karyotypes in twin pregnancies complicated with structural abnormalities].
Zhong SL; Fang Q; Chen BJ; Han ZY; Luo YM; Chen JS; Xie YJ
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):649-54. PubMed ID: 22176987
[TBL] [Abstract][Full Text] [Related]
47. [Correlation of a disintegrin and metalloprotease 12 level in maternal serum during the first trimester with pregnancy outcome].
Qi H; Bian XM; Jiang YL; Liu SY; Guo Q
Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):401-4. PubMed ID: 19953936
[TBL] [Abstract][Full Text] [Related]
48. MR imaging of the fetus by a HASTE sequence.
Yamashita Y; Namimoto T; Abe Y; Takahashi M; Iwamasa J; Miyazaki K; Okamura H
AJR Am J Roentgenol; 1997 Feb; 168(2):513-9. PubMed ID: 9016238
[TBL] [Abstract][Full Text] [Related]
49. Maternal biomarkers for fetal heart failure in fetuses with congenital heart defects or arrhythmias.
Miyoshi T; Hosoda H; Nakai M; Nishimura K; Miyazato M; Kangawa K; Ikeda T; Yoshimatsu J; Minamino N
Am J Obstet Gynecol; 2019 Jan; 220(1):104.e1-104.e15. PubMed ID: 30273582
[TBL] [Abstract][Full Text] [Related]
50. High risk-What's next? A survey study on decisional conflict, regret, and satisfaction among high-risk pregnant women making choices about further prenatal testing for fetal aneuploidy.
Hartwig TS; Borregaard Miltoft C; Malmgren CI; Tabor A; Jørgensen FS
Prenat Diagn; 2019 Jul; 39(8):635-642. PubMed ID: 31083781
[TBL] [Abstract][Full Text] [Related]
51. Central nervous system development-related microRNAs levels increase in the serum of gestational diabetic women during the first trimester of pregnancy.
Lamadrid-Romero M; Solís KH; Cruz-Reséndiz MS; Pérez JE; Díaz NF; Flores-Herrera H; García-López G; Perichart O; Reyes-Muñoz E; Arenas-Huertero F; Eguía-Aguilar P; Molina-Hernández A
Neurosci Res; 2018 May; 130():8-22. PubMed ID: 28803788
[TBL] [Abstract][Full Text] [Related]
52. Maternal smoking: effect on circulating cell-free fetal and total DNA levels in maternal plasma from the second trimester.
Lapaire O; Volgmann T; Huang D; Hahn S; Holzgreve W; Zhong XY
Obstet Gynecol; 2007 Dec; 110(6):1358-63. PubMed ID: 18055732
[TBL] [Abstract][Full Text] [Related]
53. [Prenatal MRI as a method of controlling fetal pathology].
Bekiesińska-Figatowska M; Herman-Sucharska I; Duczkowska A; Jaczyńska R; Romaniuk-Doroszewska A; Bragoszewska H; Zamłyński J
Ginekol Pol; 2013 Jun; 84(6):436-43. PubMed ID: 24032261
[TBL] [Abstract][Full Text] [Related]
54. [Prenatal gene diagnosis of paternally inherited alpha-thalassemia by detecting fetal DNA in maternal plasma].
Chen P; Li MJ; Li MQ; Li SQ; Zhou LY; Lin WX
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1540-4. PubMed ID: 17785106
[TBL] [Abstract][Full Text] [Related]
55. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
56. First and early second trimester diagnosis of anomalies of the central nervous system.
van Zalen-Sprock RM; van Vugt JM; van Geijn HP
J Ultrasound Med; 1995 Aug; 14(8):603-10. PubMed ID: 7474059
[TBL] [Abstract][Full Text] [Related]
57. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
[TBL] [Abstract][Full Text] [Related]
58. Review: advances in non-invasive prenatal diagnosis.
Vaiopoulos AG; Athanasoula KC; Papantoniou N; Kolialexi A
In Vivo; 2013; 27(2):165-70. PubMed ID: 23422474
[TBL] [Abstract][Full Text] [Related]
59. [Extracellular vesicle concentration in maternal plasma as an early marker of gestational diabetes].
Arias M; Monteiro LJ; Acuña-Gallardo S; Varas-Godoy M; Rice GE; Monckeberg M; Díaz P; Illanes SE
Rev Med Chil; 2019 Dec; 147(12):1503-1509. PubMed ID: 32186613
[TBL] [Abstract][Full Text] [Related]
60. Fetomaternal microchimerism and genetic diagnosis: On the origins of fetal cells and cell-free fetal DNA in the pregnant woman.
Rosner M; Kolbe T; Hengstschläger M
Mutat Res Rev Mutat Res; 2021; 788():108399. PubMed ID: 34893150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
